Virtual Event | September 16, 2022

The Not-So-New Challenges Of mRNA Delivery

Source: Sartorius

Walter Straps, Ph.D., CEO of Carver Biosciences states that when it comes to mRNA, the challenges associated with its delivery are anything but new. Indeed, Straps explains that challenges have existed essentially since the dawn of nucleotide therapeutics in general. “There is a joke within the oligo nucleotide field similar to the real estate industry in that in real estate it’s location, location, location; for all nucleotides it's delivery, delivery, delivery,” says Straps.

access the Virtual Event!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Drug Discovery Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

Sartorius